# Mark Egly Foundation - CME-Accredited Physician Education Program

**Document Version**: 1.0
**Last Updated**: November 7, 2025
**Owner**: Medical Education Director
**Purpose**: Design comprehensive CME program to train physicians to recognize and diagnose AATD early

---

## ðŸ“‹ Table of Contents

1. [Program Overview](#program-overview)
2. [CME Accreditation Strategy](#cme-accreditation-strategy)
3. [Course Design](#course-design)
4. [Course Content](#course-content)
5. [Delivery Methods](#delivery-methods)
6. [Marketing & Enrollment](#marketing--enrollment)
7. [Evaluation & Impact](#evaluation--impact)
8. [Scaling Strategy](#scaling-strategy)

---

## Program Overview

### The Problem

**Physicians are missing AATD diagnoses because they're not trained to recognize it.**

**Key Statistics**:

- Only 10% of U.S. physicians routinely test COPD patients for AATD (despite WHO recommendations)
- Medical schools spend minimal time on rare diseases
- Average physician graduates without exposure to AATD cases
- Diagnostic delays average 7-8 years because symptoms mimic common conditions

**The Impact**:

- Patients are misdiagnosed with asthma, COPD, or bronchitis for years
- Irreversible lung damage occurs before correct diagnosis
- Treatment opportunities are missed
- Patients suffer unnecessarily

---

### The Solution

**Free, accredited CME courses that train physicians to:**

- âœ… Recognize AATD symptoms and risk factors
- âœ… Know when to test (WHO guidelines)
- âœ… Order correct diagnostic tests
- âœ… Interpret results and refer appropriately
- âœ… Understand treatment options (augmentation therapy)
- âœ… Provide genetic counseling for families

**Result**: More physicians test for AATD â†’ Earlier diagnoses â†’ Better outcomes

---

### Program Goals

**Year 1**:

- Launch 1 foundational CME course (1.0 CME credits)
- Train 500 physicians
- Achieve 90%+ satisfaction rating
- Document 50+ AATD diagnoses resulting from course

**Year 3**:

- Expand to 3 courses (beginner, intermediate, advanced)
- Train 1,500 physicians annually
- Partner with 10 medical institutions
- Track 200+ annual diagnoses attributed to training

**Year 5**:

- Train 2,000 physicians annually (cumulative: 7,500+ trained)
- Offer courses in-person, online, and at conferences
- Achieve national recognition as premier AATD education provider
- Measurable impact: Reduce diagnostic delays in trained physicians' patients by 50%

---

## CME Accreditation Strategy

### What is CME?

**Continuing Medical Education (CME)** is required for physicians to maintain licensure. Physicians must complete a certain number of CME credits annually.

**Why CME matters for us**:

- âœ… Physicians actively seek CME courses
- âœ… Accreditation signals quality and credibility
- âœ… Free CME is highly attractive (removes cost barrier)
- âœ… Tracking CME completion = data on reach and impact

---

### Accreditation Process

**Option 1: Direct Accreditation (ACCME)**

- **Accrediting Body**: Accreditation Council for Continuing Medical Education (ACCME)
- **Process**: Apply to become accredited CME provider
- **Timeline**: 12-18 months for initial accreditation
- **Cost**: $10,000-$15,000 application fee + annual fees
- **Pros**: Full control, foundation branded, long-term investment
- **Cons**: Time-consuming, expensive, requires dedicated staff

**Option 2: Joint Providership (Partner with Accredited Institution)**

- **Process**: Partner with medical school, hospital, or CME accreditation company
- **Timeline**: 3-6 months to develop and launch course
- **Cost**: $5,000-$10,000 per course for joint providership
- **Pros**: Faster, less expensive, leverage partner's credibility
- **Cons**: Less control, partner name appears alongside foundation

**Recommendation for Year 1**: **Joint Providership**

- Faster time to market
- Lower upfront costs
- Test course demand before investing in direct accreditation
- Transition to direct accreditation in Year 2-3 once program is established

---

### Joint Providership Partners (Options)

**Medical Schools**:

- University of Arizona College of Medicine (Phoenix)
- Mayo Clinic Alix School of Medicine
- Johns Hopkins University School of Medicine
- Partner benefits: Credibility, faculty expertise, distribution channels

**CME Accreditation Companies**:

- Pri-Med (primary care CME)
- Medscape Education
- AXIS Medical Education
- Partner benefits: Accreditation infrastructure, marketing reach, tech platform

**Professional Associations**:

- American College of Chest Physicians (CHEST)
- American Thoracic Society (ATS)
- American Academy of Family Physicians (AAFP)
- Partner benefits: Built-in physician audience, conference integration

**Year 1 Target Partner**: **American College of Chest Physicians (CHEST)**

- Pulmonologists are primary AATD diagnosticians
- Large membership (19,000+ physicians)
- Established CME program
- Annual conference with 6,000+ attendees

---

### Accreditation Requirements

**To qualify for CME accreditation, course must**:

- âœ… Address identified educational need (diagnostic delays = clear need)
- âœ… Include measurable learning objectives
- âœ… Be evidence-based (cite research, guidelines)
- âœ… Be free from commercial bias (no pharmaceutical promotion)
- âœ… Include pre-test and post-test to assess learning
- âœ… Provide certificate of completion
- âœ… Collect evaluation data

**CME Credit Calculation**:

- 1 CME credit = 1 hour of instruction
- Example: 60-minute course = 1.0 CME credits

---

## Course Design

### Course 1: "AATD: Early Detection, Better Outcomes" (Foundational)

**Target Audience**: Primary care physicians, pulmonologists, internists

**Duration**: 60 minutes (1.0 CME credits)

**Learning Objectives**:
By the end of this course, participants will be able to:

1. Identify patients who should be tested for AATD based on WHO guidelines
2. Order appropriate diagnostic tests (AAT level, genotyping)
3. Interpret AATD test results and refer appropriately
4. Explain augmentation therapy to patients
5. Provide genetic counseling and recommend family testing

**Format**: Online, self-paced (video modules + interactive quiz)

---

### Course Modules

**Module 1: AATD Overview (10 minutes)**

- What is Alpha-1 Antitrypsin Deficiency?
- Genetics: SERPINA1 gene mutations (ZZ, SZ, MZ)
- Prevalence: 1 in 2,500 individuals (severe AATD)
- Lung and liver manifestations
- Natural history and prognosis

**Module 2: Why Diagnostic Delays Happen (10 minutes)**

- Average delay: 7-8 years, 4+ doctors
- Symptoms mimic asthma, COPD, bronchitis
- Case study: Patient misdiagnosed for years
- Consequences: Irreversible lung damage, missed treatment
- Malpractice risk (see next document)

**Module 3: Who to Test (15 minutes)**

- WHO guidelines: Test all COPD patients
- Additional indications:
  - Unexplained liver disease (any age)
  - Family history of AATD
  - Early-onset emphysema (<45 years)
  - Bronchiectasis without obvious cause
  - Persistent asthma unresponsive to treatment
  - Necrotizing panniculitis
  - Granulomatosis with polyangiitis (Wegener's)
- High-risk occupations: Firefighters, military, miners
- Interactive case studies: "Should you test this patient?"

**Module 4: How to Test & Interpret Results (15 minutes)**

- Step 1: Order AAT serum level
  - Normal: >150 mg/dL
  - Low: <100 mg/dL â†’ proceed to genotyping
- Step 2: Genotyping (if AAT low)
  - Common genotypes: MM (normal), ZZ (severe), SZ, MZ
  - Phenotyping vs. genotyping
- Step 3: Referral to pulmonologist or AATD specialist
- Insurance coverage and coding (CPT codes)
- Sample orders and lab requisitions

**Module 5: Treatment & Management (10 minutes)**

- Augmentation therapy: Weekly IV infusions of AAT protein
  - Slows progression of emphysema
  - Not curative, but improves outcomes
  - FDA-approved products: Prolastin, Aralast, Glassia, Zemaira
- Standard COPD management: Bronchodilators, pulmonary rehab, oxygen
- Lifestyle modifications: Smoking cessation (critical!), avoid lung irritants
- Liver disease management: Transplant if severe
- Genetic counseling: Family members should be tested
- Where to refer: Alpha-1 centers of excellence

---

### Interactive Elements

**Pre-Test (5 questions)**:

- Assess baseline knowledge before course
- Questions on AATD recognition, testing, treatment

**Case Studies (Embedded in Modules)**:

- Interactive scenarios: "What would you do?"
- Immediate feedback on answers

**Post-Test (10 questions)**:

- Assess learning after course
- Must score 70%+ to receive CME credit
- Can retake if needed

**Evaluation Survey**:

- Course quality (1-5 scale)
- Relevance to practice
- Likelihood to change practice (key outcome)
- Suggestions for improvement

---

### Faculty & Content Development

**Course Director**: Mark Egly Foundation Medical Director (hire by Q2 Year 1)

**Faculty (Subject Matter Experts)**:

- Pulmonologist with AATD expertise (course presenter)
- Genetic counselor (family testing section)
- AATD patient (share story for emotional impact)

**Content Development Process**:

1. Conduct needs assessment (survey physicians on AATD knowledge gaps)
2. Develop learning objectives
3. Script modules (evidence-based, cite research)
4. Record video lectures (professional production)
5. Develop interactive quizzes
6. Peer review by AATD experts
7. Submit to CME accreditation partner for approval
8. Launch and iterate based on feedback

**Timeline**: 6 months from kickoff to launch

---

## Course Content

### Evidence-Based Guidelines

**Course content cites**:

- WHO recommendations (test all COPD patients for AATD)
- ATS/ERS guidelines for AATD diagnosis and management
- Research studies on diagnostic delays and outcomes
- Clinical trial data on augmentation therapy efficacy

**No Commercial Bias**:

- Course funded by Mark Egly Foundation (nonprofit, unrestricted)
- No pharmaceutical company sponsorship
- Augmentation therapy products mentioned generically (not branded promotion)

---

### Tone & Style

**Professional but Accessible**:

- Medical terminology used but explained
- Clinical, not sensational
- Respectful of physician expertise
- Empowering: "You can make a difference by testing"

**Patient-Centered**:

- Emphasize impact of delays on patients
- Include patient stories
- Frame early detection as patient advocacy

---

## Delivery Methods

### Year 1: Online, Self-Paced

**Platform**: Learning Management System (LMS)

- Options: Litmos, TalentLMS, or partner's existing platform (e.g., CHEST LMS)
- Features:
  - Video hosting
  - Interactive quizzes
  - Progress tracking
  - Certificate generation
  - Evaluation surveys

**User Experience**:

1. Physician registers (name, email, NPI number, specialty)
2. Watches video modules (can pause/resume)
3. Completes interactive quizzes
4. Takes post-test (70% to pass)
5. Receives CME certificate via email
6. Completes evaluation survey

**Accessibility**:

- Mobile-friendly (physicians can complete on phone/tablet)
- Closed captions on all videos
- Downloadable slides (PDF)

---

### Year 2: Expand Delivery Options

**Live Webinars** (2-4 per year):

- Real-time presentation with Q&A
- More interactive than self-paced
- Can address current AATD news or research
- Record and offer as on-demand afterward

**Conference Workshops** (CHEST, ATS, AAFP annual conferences):

- In-person or hybrid sessions
- 60-90 minutes
- CME credit awarded on-site
- Networking opportunity with AATD experts

**Grand Rounds** (at medical institutions):

- Partner with 10 hospitals/medical schools
- Present AATD course as grand rounds (1 hour)
- Reach residents, fellows, faculty
- Build institutional relationships

---

### Year 3+: Advanced Courses

**Course 2: "Advanced AATD Management" (Intermediate)**

- Target: Pulmonologists, AATD specialists
- Topics: Complex cases, augmentation therapy optimization, lung transplant, clinical trials
- 2.0 CME credits

**Course 3: "AATD for Primary Care" (Beginner)**

- Target: Family medicine, internal medicine
- Topics: When to suspect, when to refer, genetic counseling basics
- 0.5 CME credits (30 minutes)

**Pediatric AATD Course**:

- Target: Pediatricians, pediatric pulmonologists
- Topics: Newborn screening, pediatric liver disease, growth and development
- 1.0 CME credits

---

## Marketing & Enrollment

### Target Audience

**Primary**:

- Pulmonologists (19,000 in U.S.)
- Primary care physicians (200,000+ in U.S.)
  - Family medicine
  - Internal medicine
  - General practice

**Secondary**:

- Gastroenterologists (liver disease)
- Genetic counselors
- Nurse practitioners / Physician assistants

**Year 1 Goal**: 500 physicians (focus on pulmonologists first)

---

### Marketing Channels

**1. Professional Associations**:

- CHEST (American College of Chest Physicians)
  - Email to 19,000 members
  - Promotion in CHEST journal and e-newsletter
  - Featured on CHEST website
- ATS (American Thoracic Society)
- AAFP (American Academy of Family Physicians)

**2. Medical Conferences**:

- Booth at CHEST annual meeting
  - "Take our free CME course on AATD" signage
  - QR code for instant enrollment
  - Branded swag (pens, notepads with course info)
- Sponsored sessions or lunch symposiums

**3. Email Marketing**:

- Purchase physician email lists (specialty: pulmonology, primary care)
- Email campaign: "Free 1.0 CME Credit: Learn to Diagnose AATD"
- 3-email series: Awareness â†’ Benefits â†’ Enrollment

**4. Social Media** (LinkedIn, Doximity):

- Ads targeting physicians
- Organic posts in physician groups
- Testimonials from course completers

**5. Direct Outreach**:

- Physician outreach volunteers (see Volunteer Program doc)
- Cold calls to medical practices: "We're offering free CME..."
- Partner with pharmaceutical reps (who call on pulmonologists)

**6. SEO & Website**:

- Dedicated landing page: markeglyfoundation.org/cme
- Optimized for "AATD CME," "Alpha-1 CME," "free pulmonary CME"
- Google Ads targeting physicians searching for CME

---

### Enrollment Process

**Step 1: Marketing drives traffic to course landing page**

**Step 2: Landing page includes**:

- Course description and learning objectives
- Faculty bios
- Free CME credit badge (1.0 credits)
- Testimonials from beta testers
- "Enroll Now" button

**Step 3: Registration form**:

- Name, email, NPI number
- Specialty, state
- How did you hear about us?

**Step 4: Confirmation email**:

- Login credentials for LMS
- Instructions to start course
- Reminder: "Complete by [date] to receive certificate"

---

### Incentives & Gamification

**Completion Badge**:

- Digital badge: "AATD Aware Physician"
- Share on LinkedIn or email signature

**AATD Aware Certification** (see next document):

- Physicians who complete CME + commit to testing can earn certification seal
- Display on website, marketing materials

**Leaderboard** (optional):

- Top states by enrollment
- Friendly competition

**Referral Program**:

- Refer a colleague â†’ Both get entered in raffle for [prize]

---

## Evaluation & Impact

### Course Evaluation Metrics

**Quantitative**:

- **Enrollment**: Number of physicians registered
- **Completion Rate**: % who finish course and pass post-test
- **Pre-Test vs. Post-Test Scores**: Measure knowledge gain
- **Satisfaction Rating**: Average score (1-5 scale)
- **Likelihood to Recommend**: Net Promoter Score

**Qualitative**:

- **Open-Ended Feedback**: What did you like? What could improve?
- **Practice Change**: "How will this course change your practice?"

**Year 1 Targets**:

- Enrollment: 500 physicians
- Completion rate: 80%+
- Knowledge gain: +30% (pre-test to post-test)
- Satisfaction: 4.5/5.0
- NPS: 70+

---

### Impact Tracking (Long-Term)

**Question**: _Does CME course lead to more AATD diagnoses?_

**How to Track**:

**Method 1: Post-Course Survey (3-6 months after completion)**

- Email survey to course completers
- Questions:
  - Have you tested any patients for AATD since taking this course? (Yes/No)
  - If yes, how many? (Number)
  - How many were diagnosed with AATD? (Number)
  - Would you have tested these patients before taking the course? (Yes/No/Unsure)

**Method 2: Physician Self-Reporting**

- Optional: Physicians can submit case reports
- Form: "I diagnosed an AATD patient as a result of your CME course"
- Collect anonymized data (no PHI)

**Method 3: Partner with Labs**

- Partner with AATD testing labs (e.g., AlphaID, Grifols)
- Track: Are more tests being ordered by course-completing physicians?
- Compare: Test volume by trained vs. untrained physicians

**Method 4: National Data Analysis**

- Long-term: Analyze national AATD diagnosis trends
- Hypothesis: Regions with higher CME enrollment â†’ shorter diagnostic delays

**Year 1 Impact Goal**: Document 50+ AATD diagnoses attributed to CME course

---

### Continuous Improvement

**Quarterly Review**:

- Analyze enrollment, completion, satisfaction data
- Identify drop-off points (which modules have low completion?)
- Review open-ended feedback for themes

**Annual Course Update**:

- Update content with latest research
- Revise based on feedback
- Re-accreditation (CME credits typically valid 1-3 years)

**A/B Testing**:

- Test different marketing messages
- Test different course formats (video length, quiz frequency)
- Optimize for completion and satisfaction

---

## Scaling Strategy

### Year 1: Proof of Concept

**Goal**: Launch 1 course, train 500 physicians, validate model

**Key Activities**:

- Develop foundational course
- Secure CME accreditation (joint providership)
- Launch marketing campaigns
- Track enrollment, completion, satisfaction
- Document impact (diagnoses attributed to course)

**Budget**: $150,000

- Course development: $50,000
- CME accreditation: $10,000
- Marketing: $50,000
- LMS platform: $10,000
- Staff (Medical Education Director, 0.5 FTE): $30,000

---

### Year 2: Expand & Optimize

**Goal**: Train 1,000 physicians, launch 2nd course, expand distribution

**Key Activities**:

- Optimize foundational course based on Year 1 feedback
- Develop 2nd course (Advanced AATD Management or Primary Care version)
- Launch live webinars (2-4 per year)
- Present at 3 medical conferences
- Partner with 5 medical schools for grand rounds

**Budget**: $250,000

- New course development: $50,000
- Marketing expansion: $100,000
- Conference sponsorships: $30,000
- Staff (Medical Education Director, 1.0 FTE): $70,000

---

### Year 3: National Reach

**Goal**: Train 1,500 physicians annually, 3 courses, direct accreditation

**Key Activities**:

- Apply for direct ACCME accreditation (become own CME provider)
- Launch 3rd course (Pediatric AATD or subspecialty)
- Host annual AATD Medical Symposium (1-day conference, 6 CME credits)
- Publish impact data: "CME course reduces diagnostic delays by X%"
- Partner with 10 medical institutions for grand rounds

**Budget**: $400,000

- Direct accreditation: $15,000
- New course: $50,000
- Annual symposium: $100,000
- Marketing: $150,000
- Staff: $85,000

---

### Year 5: Thought Leadership

**Goal**: Train 2,000 physicians annually, recognized as national AATD education leader

**Key Activities**:

- 5+ CME courses covering full AATD spectrum
- Annual symposium attracts 500+ attendees
- Partner with medical schools to integrate AATD into curriculum
- Publish in medical education journals
- Influence medical board exams (include AATD questions)

**Budget**: $600,000

---

### Geographic Expansion

**Year 1-2**: National (online course available everywhere)

**Year 3+**: International

- Translate course into Spanish (Latin America)
- Partner with European Respiratory Society (ERS) for European CME
- Adapt content for other countries' healthcare systems

---

## Partnerships & Collaborations

### Medical Schools

**Goal**: Integrate AATD education into medical school curriculum

**Approach**:

- Offer free CME course to medical students and residents
- Guest lectures in pulmonology rotations
- Case studies in problem-based learning curricula

**Pilot Partners** (Year 2):

- University of Arizona College of Medicine
- Johns Hopkins University School of Medicine
- Mayo Clinic Alix School of Medicine

---

### Pharmaceutical Companies

**Ethical Consideration**: Maintain independence, avoid commercial bias

**Approach**:

- Accept unrestricted educational grants (no strings attached)
- Do NOT allow pharma to influence course content
- Do NOT promote specific products
- Disclose all funding sources transparently

**Potential Funders**:

- Grifols (Prolastin manufacturer)
- CSL Behring (Zemaira manufacturer)
- Takeda (Glassia manufacturer)

**Year 1**: Do NOT seek pharma funding (maintain credibility)
**Year 2+**: Consider unrestricted grants if demand exceeds foundation budget

---

### Professional Associations

**CHEST (American College of Chest Physicians)**:

- Joint providership partner (Year 1)
- Conference presentations and booths
- Email marketing to membership

**ATS (American Thoracic Society)**:

- Similar partnership model
- Leverage annual conference (6,000+ attendees)

**AAFP (American Academy of Family Physicians)**:

- Primary care physician outreach
- FP-specific course version

---

### Testing Labs

**Partnership Goal**: Track testing volume and outcomes

**Partners**:

- AlphaID (Grifols' AATD testing program)
- University of Florida AATD Testing Laboratory
- Commercial labs (Quest, LabCorp)

**Collaboration**:

- Share de-identified data on testing trends
- Co-market: "Order an AATD test, learn more at MarkEglyFoundation.org/CME"

---

## Summary: CME as a Force Multiplier

**Why CME Works**:

- âœ… Physicians need CME â†’ Built-in demand
- âœ… Free CME removes cost barrier
- âœ… Online delivery = scalable (500 â†’ 2,000+ physicians)
- âœ… Credible, evidence-based education
- âœ… Direct impact: Trained physicians diagnose AATD earlier

**The Multiplier Effect**:

- 1 trained physician diagnoses 10 AATD patients over career
- 500 trained physicians (Year 1) = 5,000 potential diagnoses
- 2,000 trained annually (Year 5) = 20,000 diagnoses over 10 years

**Our north star metric**: Reduce diagnostic delays
**CME is the vehicle**: Educate physicians â†’ Earlier testing â†’ Earlier diagnosis â†’ Better outcomes

---

**Next Steps** (Year 1, Q1-Q2):

1. âœ… Hire Medical Education Director
2. âœ… Secure joint providership with CHEST
3. âœ… Develop foundational CME course
4. âœ… Submit for accreditation approval
5. âœ… Build LMS platform
6. âœ… Launch marketing campaign
7. âœ… Enroll first 500 physicians

---

**Approved by**: Mark Egly Foundation Board of Directors
**Effective Date**: November 7, 2025
**Review Date**: Annually
**Version**: 1.0

---

_"Every physician we train is a sentinel in the fight against diagnostic delays."_

**â€” Mark Egly Foundation Medical Education Team**
